1. Home
  2. KRYS vs GBCI Comparison

KRYS vs GBCI Comparison

Compare KRYS & GBCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$246.66

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Logo Glacier Bancorp Inc.

GBCI

Glacier Bancorp Inc.

HOLD

Current Price

$46.57

Market Cap

5.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRYS
GBCI
Founded
2015
1955
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
5.9B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
KRYS
GBCI
Price
$246.66
$46.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
5
Target Price
$226.56
$53.60
AVG Volume (30 Days)
289.5K
875.4K
Earning Date
02-18-2026
01-22-2026
Dividend Yield
N/A
2.79%
EPS Growth
275.72
26.70
EPS
6.66
2.05
Revenue
$373,164,000.00
$900,148,000.00
Revenue This Year
$36.14
$13.47
Revenue Next Year
$41.80
$27.72
P/E Ratio
$37.43
$23.04
Revenue Growth
54.51
15.35
52 Week Low
$122.80
$36.76
52 Week High
$265.92
$52.81

Technical Indicators

Market Signals
Indicator
KRYS
GBCI
Relative Strength Index (RSI) 60.83 61.69
Support Level $235.61 $43.14
Resistance Level $257.95 $47.31
Average True Range (ATR) 7.62 1.09
MACD -1.55 0.11
Stochastic Oscillator 57.06 80.91

Price Performance

Historical Comparison
KRYS
GBCI

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About GBCI Glacier Bancorp Inc.

Glacier Bancorp Inc is a regional bank holding company providing commercial banking services to scores of communities through its wholly-owned bank subsidiary, Glacier Bank. The bank operates a multitude of banking offices in Montana, Idaho, Colorado, Utah, Washington, and Wyoming. The bank's various products and services include deposit, loans, and mortgage origination services, among others. The bank predominantly serves individuals, small- to medium-sized businesses, community organizations, and public entities. Glacier emphasizes both internal growth and growth through selective acquisitions. A majority of the bank's loan portfolio is in commercial real estate, while a majority of its net revenue is net interest income.

Share on Social Networks: